Edwards Lifesciences EW
NYSE EW
$89.79 -0.04 (-0.04%)
At close: Aug 21, 2026 · 4:00 PM EDT

Edwards Lifesciences (EW) Invested Capital (2009 - 2018)

Edwards Lifesciences (EW) posted quarterly Invested Capital of $598.6 million for Q1 2018, up 1057.83% quarter-over-quarter from $51.7 million in Q4 2017.

Edwards Lifesciences (EW) Invested Capital (2009 - 2018) Analysis & Trends

Edwards Lifesciences' Invested Capital history runs 6 years deep, the most recent figure standing at $598.6 million for Q1 2018.

  • In Q1 2018, Invested Capital changed N/A year-over-year to $598.6 million; the TTM figure through Dec 2018 stood at $598.6 million (up 542.27% YoY), while the FY2017 annual figure was $51.7 million, changed N/A from the prior year.
  • Invested Capital for Q1 2018 stood at $598.6 million, up from $51.7 million in the prior quarter.
  • The five-year high for Invested Capital was $598.6 million in Q1 2018, with the low at $41.5 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 3.01 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 750.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 1.71 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 2.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 243.40 Mn
10 Zimmer Biomet Holdings 19.42 Bn 19.01 Bn 1.54 Bn 1.20 Bn

Historic Data

Download Data
DateValue
Sep 30, 2018 599.90 Mn
Jun 30, 2018 599.20 Mn
Mar 31, 2018 598.60 Mn
Dec 31, 2017 51.70 Mn
Sep 30, 2017 41.50 Mn
Dec 31, 2012 189.30 Mn
Dec 31, 2011 150.40 Mn
Mar 31, 2011 149.50 Mn
Dec 31, 2010 41.80 Mn
Sep 30, 2010 100.60 Mn
Dec 31, 2009 11.40 Mn